Buy Aurobindo Pharma; target of Rs 850: Axis Direct News News / News 7 years ago 622 Views comments Axis Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 850 in its research report dated July 24,... Read more
News 2,000 SSB staffers to go to Intelligence Bureau; govt approves border snoop plan News / News - 7 years ago
News North Korea #39;great threat and embarrassment#39; to China: Donald Trump News / News - 7 years ago
News India-Pakistan talks meaningless unless Pakistan changes course: Report News / News - 7 years ago
Comments